REAL-TIMI 63B

REAL-TIMI 63B is a Phase 2b randomized, blinded, placebo controlled study to evaluate the efficacy, safety, PK/pharmacodynamic, and immunogenicity of repeat doses of MEDI6012 in adult subjects presenting with acute STEMI (ST segment elevation myocardial infarction).

REAL-TIMI 63B

PRESENTATIONS

Preliminary Results – Cardioprotection and Plaque Regression with MEDI6012 in Acute ST Elevation Myocardial Infarction – Primary Results of the Phase 2B REAL-TIMI 63B Randomized Clinical Trial (Bonaca, ACC 2021)

REAL on ClinicalTrials.gov

CONTACT US About REAL

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close